Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
Andreas Hochhaus(University of Mannheim), Sebastian Kreil(University of Mannheim), A. Corbin(Oregon Health & Science University), Paul La Rosée(Oregon Health & Science University), MC Müller(University of Mannheim), Tanja Lahaye(University of Mannheim), Benjamin Hanfstein(University of Mannheim), Claudia Schoch, NCP Cross(Wessex Regional Genetics Laboratory), Ute Berger(University of Mannheim), Harald Gschaidmeier(Novartis (Germany)), Brian Druker(Oregon Health & Science University), Rüdiger Hehlmann(University of Mannheim)
Cited by 904
Abstract
Related Papers
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus et al.|New England Journal of Medicine|2002|2k